Ovarian cancer: novel molecular aspects for clinical assessment

Ovarian cancer is a very heterogeneous tumor which has been traditionally characterized according to the different histological subtypes and differentiation degree. In recent years, innovative molecular screening biotechnologies have allowed to identify further subtypes of this cancer based on gene expression profiles, mutational features, and epigenetic factors. These novel classification systems emphasizing the molecular signatures within the broad spectrum of ovarian cancer have not only allowed a more precise prognostic prediction, but also proper therapeutic strategies for specific subgroups of patients. (Source: Critical Reviews in Oncology Hematology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2rJ0BIp
via IFTTT